-
1
-
-
0029954843
-
P-glycoprotein-a mediator of multidrug resistance in tumour cells
-
Germann UA. P-glycoprotein-a mediator of multidrug resistance in tumour cells. Eur J Cancer 1996; 32A: 927-44.
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 927-944
-
-
Germann, U.A.1
-
2
-
-
0027218689
-
Biochemistry of multidrug resistance mediated by the multidrug transporter
-
Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
-
(1993)
Annu Rev Biochem
, vol.62
, pp. 385-427
-
-
Gottesman, M.M.1
Pastan, I.2
-
3
-
-
0028249115
-
The MDR superfamily of genes and its biological implications
-
Childs S, Ling V. The MDR superfamily of genes and its biological implications. Important Adv Oncol 1994; 21-36.
-
(1994)
Important Adv Oncol
, pp. 21-36
-
-
Childs, S.1
Ling, V.2
-
4
-
-
2342436512
-
PET studies on P-glycoprotein function in the blood-brain barrier: How it affects uptake and binding of drugs within the CNS
-
Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A. PET studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr Pharm Des 2004; 10: 1493-503.
-
(2004)
Curr Pharm des
, vol.10
, pp. 1493-1503
-
-
Elsinga, P.H.1
Hendrikse, N.H.2
Bart, J.3
Vaalburg, W.4
Van Waarde, A.5
-
5
-
-
0142105939
-
In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier
-
Cisternino S, Rousselle C, Debray M, Scherrmann JM. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Pharm Res 2003; 20: 1607-11.
-
(2003)
Pharm Res
, vol.20
, pp. 1607-1611
-
-
Cisternino, S.1
Rousselle, C.2
Debray, M.3
Scherrmann, J.M.4
-
6
-
-
0037036215
-
Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice
-
Zhao YL, Du J, Kanazawa H, Sugawara A, Takagi K, Kitaichi K, et al. Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice. Eur J Pharmacol 2002; 445: 115-23.
-
(2002)
Eur J Pharmacol
, vol.445
, pp. 115-123
-
-
Zhao, Y.L.1
Du, J.2
Kanazawa, H.3
Sugawara, A.4
Takagi, K.5
Kitaichi, K.6
-
7
-
-
0027998226
-
In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin a at the blood-brain barrier
-
Sakata A, Tamai I, Kawazu K, Deguchi Y, Ohnishi T, Saheki A, et al. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994; 48: 1989-92.
-
(1994)
Biochem Pharmacol
, vol.48
, pp. 1989-1992
-
-
Sakata, A.1
Tamai, I.2
Kawazu, K.3
Deguchi, Y.4
Ohnishi, T.5
Saheki, A.6
-
8
-
-
0023892070
-
Modification of cytotoxic drug resistance by nonimmuno-suppressive cyclosporins
-
Twentyman PR. Modification of cytotoxic drug resistance by nonimmuno-suppressive cyclosporins. Br J Cancer 1988; 57: 254-8.
-
(1988)
Br J Cancer
, vol.57
, pp. 254-258
-
-
Twentyman, P.R.1
-
9
-
-
0033053573
-
Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp)
-
Aszalos A, Thompson K, Yin JJ, Ross DD. Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp). Anticancer Res 1999; 19: 1053-64.
-
(1999)
Anticancer Res
, vol.19
, pp. 1053-1064
-
-
Aszalos, A.1
Thompson, K.2
Yin, J.J.3
Ross, D.D.4
-
10
-
-
10744219744
-
Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: Comparison with a long-acting calcium channel antagonist, amlodipine
-
Ohbayashi Y, Tsutamoto T, Sakaguchi T, Tanaka T, Kanamori T, Yokohama H, et al. Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine. J Cardiovasc Pharmacol 2003; 42 Suppl 1: S71-4.
-
(2003)
J Cardiovasc Pharmacol
, vol.42
, Issue.SUPPL. 1
-
-
Ohbayashi, Y.1
Tsutamoto, T.2
Sakaguchi, T.3
Tanaka, T.4
Kanamori, T.5
Yokohama, H.6
-
11
-
-
0033636618
-
Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: Comparison with the effects on CYP3A4
-
Katoh M, Nakajima, M, Yamazaki H, Yokoi T. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. Pharm Res 2000; 17: 1189-97.
-
(2000)
Pharm Res
, vol.17
, pp. 1189-1197
-
-
Katoh, M.1
Nakajima, M.2
Yamazaki, H.3
Yokoi, T.4
-
12
-
-
0026793292
-
Development and characterization of a rat brain capillary endothelial culture: Towards an in vitro blood-brain barrier
-
Abbott NJ, Hughes CC, Revest PA, Greenwood J. Development and characterization of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci 1992; 103: 23-37.
-
(1992)
J Cell Sci
, vol.103
, pp. 23-37
-
-
Abbott, N.J.1
Hughes, C.C.2
Revest, P.A.3
Greenwood, J.4
-
13
-
-
0030604062
-
Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers
-
Fontaine M, Elmquist WF, Miller DW. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci 1996; 59: 1521-31.
-
(1996)
Life Sci
, vol.59
, pp. 1521-1531
-
-
Fontaine, M.1
Elmquist, W.F.2
Miller, D.W.3
-
14
-
-
0036195976
-
Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein
-
Sarver JG, Klis WA, Byers JP, Erhardt PW. Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein. J Biomol Screen 2002; 7: 29-34.
-
(2002)
J Biomol Screen
, vol.7
, pp. 29-34
-
-
Sarver, J.G.1
Klis, W.A.2
Byers, J.P.3
Erhardt, P.W.4
-
15
-
-
0030823912
-
P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain
-
Beaulieu E, Demeule M, Ghitescu L, Beliveau R. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J 1997; 326 ( Pt 2): 539-44.
-
(1997)
Biochem J
, vol.326
, Issue.PART 2
, pp. 539-544
-
-
Beaulieu, E.1
Demeule, M.2
Ghitescu, L.3
Beliveau, R.4
-
16
-
-
0242557605
-
Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells
-
Zhu HJ, Liu GQ. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells. Acta Pharmacol Sin 2003; 24: 1143-9.
-
(2003)
Acta Pharmacol Sin
, vol.24
, pp. 1143-1149
-
-
Zhu, H.J.1
Liu, G.Q.2
-
17
-
-
0036299716
-
Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells
-
He L, Liu GQ. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. Acta Pharmacol Sin 2002; 23: 591-6.
-
(2002)
Acta Pharmacol Sin
, vol.23
, pp. 591-596
-
-
He, L.1
Liu, G.Q.2
-
18
-
-
0035371207
-
Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells
-
Green LJ, Marder P, Slapak CA. Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells. Biochem Pharmacol 2001; 61: 1393-9.
-
(2001)
Biochem Pharmacol
, vol.61
, pp. 1393-1399
-
-
Green, L.J.1
Marder, P.2
Slapak, C.A.3
|